PRO-DRUG FORM (P2PDOX) OF THE HIGHLY POTENT 2-PYRROLINODOXORUBICIN CONJUGATED TO ANTIBODIES FOR TARGETED THERAPY OF CANCER

Disclosed are methods, compositions and uses of conjugates of prodrug forms of 2-pyrrolinodoxorubicin (P2PDox) with antibodies or antigen-binding fragments thereof (ADCs), with targetable construct peptides or with other targeting molecules that are capable of delivering the P2PDox to a targeted cel...

Full description

Saved in:
Bibliographic Details
Main Authors Sathyanarayan Nalini, Govindan Serengulam V, Mazza-Ferreira Christine, Goldenberg David M, McBride William J
Format Patent
LanguageEnglish
Published 21.09.2017
Subjects
Online AccessGet full text

Cover

Loading…